TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 109 filers reported holding TREACE MED CONCEPTS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,600,088 | -46.4% | 122,051 | +4.6% | 0.00% | -100.0% |
| Q2 2023 | $2,986,158 | -4.2% | 116,738 | -5.6% | 0.00% | 0.0% |
| Q1 2023 | $3,116,029 | +409.8% | 123,701 | +365.3% | 0.00% | – |
| Q4 2022 | $611,212 | -14.0% | 26,586 | -17.5% | 0.00% | – |
| Q3 2022 | $711,000 | +259.1% | 32,228 | +133.8% | 0.00% | – |
| Q2 2022 | $198,000 | -83.0% | 13,784 | -77.7% | 0.00% | – |
| Q1 2022 | $1,168,000 | +220.9% | 61,739 | +429.9% | 0.00% | – |
| Q2 2021 | $364,000 | – | 11,651 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,907,823 | $25,011,560 | 2.31% |
| FORMULA GROWTH LTD | 222,269 | $2,913,947 | 0.99% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,193,939 | $15,652,540 | 0.94% |
| EMERALD ADVISERS, LLC | 1,473,281 | $19,314,713 | 0.94% |
| Perceptive Advisors | 1,834,060 | $24,044,527 | 0.80% |
| NEXT CENTURY GROWTH INVESTORS LLC | 512,738 | $6,721,995 | 0.73% |
| OBERWEIS ASSET MANAGEMENT INC/ | 355,600 | $4,661,916 | 0.50% |
| Novo Holdings A/S | 360,000 | $4,719,600 | 0.35% |
| TimesSquare Capital Management, LLC | 1,433,429 | $18,792 | 0.29% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 677,733 | $8,885,080 | 0.18% |